Louria Hayon Igal (CIK 1903781) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-06). Recent activity: Buy RAPH (350,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-06 | Raphael Pharmaceutical Inc. (RAPH) | Chief Technology Officer | Buy | 350,000 | $3,500 |
来源：SEC Form 4 申报文件 · 截至 2026-04-06